Keyphrases
Exercise Training
100%
Heart Failure with Preserved Ejection Fraction (HFpEF)
100%
Patients with Heart Failure
100%
High-sensitivity Cardiac Troponin
100%
Training Group
62%
Supervised Exercise
62%
Comorbidity
37%
Left Ventricular End-diastolic Diameter
37%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
37%
Functional Capacity
25%
VO2peak
25%
Between-group Difference
25%
Regular Exercise
25%
High-intensity Interval Training
25%
Moderate Continuous Training
25%
Filling Pressure
12%
No Significant Difference
12%
Hypertension
12%
Serum Levels
12%
Structured Control
12%
Potential Difference
12%
Exercise Intervention
12%
Structured Exercise
12%
Intervention Group
12%
Chronic Heart Failure
12%
Peptide Concentration
12%
Linear Mixed Model
12%
Type 1 Diabetes Mellitus (T1DM)
12%
Chronic Obstructive Pulmonary Disease
12%
Natriuretic Peptides
12%
Whole Population
12%
Exercise Group
12%
Myocardial Injury
12%
Left Ventricular Remodeling
12%
Atrial Fibrillation
12%
New York Heart Association Class
12%
Hs-cTnT
12%
Reduced Ejection Fraction
12%
Structured Intervention
12%
Exercise Training Program
12%
Medicine and Dentistry
Exercise
100%
Cardiac Troponin
100%
Troponin I
100%
Heart Failure with Reduced Ejection Fraction
100%
Amino Terminal Sequence
37%
Brain Natriuretic Peptide
37%
Functional Status
25%
High Intensity Interval Training
25%
Heart Failure
12%
Diabetes Mellitus
12%
Mixed Model
12%
Chronic Obstructive Pulmonary Disease
12%
Heart Ventricle Remodeling
12%
Heart Muscle Injury
12%
Ejection Fraction
12%
New York Heart Association Class
12%
Atrial Fibrillation
12%
Natriuretic Factor
12%
Biochemistry, Genetics and Molecular Biology
Cardiac Troponin
100%
Exercise
100%
Heart Ejection Fraction
100%
Troponin I
100%
N-Terminus
37%
Brain Natriuretic Peptide
37%
High Intensity Interval Training
25%
Functional Status
25%
Natriuretic Peptide
12%
Blood Level
12%
Atrial Fibrillation
12%
Potential Difference
12%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure with Reduced Ejection Fraction
100%
Troponin I
100%
Brain Natriuretic Peptide
37%
Functional Status
25%
Chronic Obstructive Lung Disease
12%
Mixed Model
12%
Heart Ventricle Remodeling
12%
Heart Failure
12%
Heart Muscle Injury
12%
Natriuretic Factor
12%
Diabetes Mellitus
12%
Atrial Fibrillation
12%
Immunology and Microbiology
Exercise
100%
Heart Ejection Fraction
100%
Amino Terminal Sequence
42%
Functional Status
28%
High Intensity Interval Training
28%
Blood Level
14%
Potential Difference
14%